Cite

    Graeme Fraser et al.. “The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: a randomized, placebo-controlled, double-blind, dose-ranging study.” Maturitas, vol. 124, 2019, pp. 135–. http://access.bl.uk/ark:/81055/vdc_100083739921.0x00002c